SFX by Ex Libris Inc.

Title:	The peptidergic control circuit for sighing
Source:	Nature [0028-0836] Li, P yr:2016

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	McCarroll, Aswin E. "Schizophrenia risk from complex variation of complement component 4." Nature 530.7589 (2016): 177-83.
description	2.	TEIGEN, KARL H. "Is a sigh “just a sigh”? Sighs as emotional signals and responses to a difficult task." Scandinavian journal of psychology 49.1 (2008): 49-57.
description	3.	Won, H. "Chromosome conformation elucidates regulatory relationships in developing human brain." Nature 538.7626 (2016): 523-527.
description	4.	Ripke, Stephan C. "Biological insights from 108 schizophrenia-associated genetic loci." Nature 511.7510 (2014): 421-427.
description	5.	Cross-Disorder Group of the Psychiatric Genomics Consortium, Patrick F. "Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis." Lancet (London, England) 381.9875 (2013): 1371-1379.
description	6.	Stevens, B. "The classical complement cascade mediates CNS synapse elimination." Cell 131.6 (2007): 1164-1178.
description	7.	Eerland, A. "Leaning to the Left Makes the Eiffel Tower Seem Smaller: Posture-Modulated Estimation." Psychological science 22.12 (2011): 1511-1514.
description	8.	Vlemincx, E. "Why do you sigh? Sigh rate during induced stress and relief." Psychophysiology 46.5 (2009): 1005-1013.
description	9.	Sherman, L W W. "An ecological study of glee in small groups of preschool children." Child development 46.1 (1975): 53-61.
description	10.	Degenhardt, L. "Testing hypotheses about the relationship between cannabis use and psychosis." Drug and Alcohol Dependence 71.1 (2003): 37-48.
description	11.	Schafer, Dorothy P. "Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner." Neuron 74.4 (2012): 691-705.
description	12.	Power, P A F G. "Genetic predisposition to schizophrenia associated with increased use of cannabis." Molecular Psychiatry 19.11 (2014): 1201-4.
description	13.	Wray, N. "Common polygenic variation contributes to risk of schizophrenia and bipolar disorder." Nature 460.7256 (2009): 748-752.
description	14.	Bersani, G. "Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes." European archives of psychiatry and clinical neuroscience 252.2 (2002): 86-92.
description	15.	Sklar, P. "A polygenic burden of rare disruptive mutations in schizophrenia." Nature 506.7487 (2014): 185-190.
description	16.	Ruderfer, D M M. "Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia." Molecular Psychiatry 19.9 (2013): 1017-1024.
description	17.	Fergusson, M. "Tests of causal linkages between cannabis use and psychotic symptoms." Addiction 100.3 (2005): 354-366.
description	18.	Arseneault, L. "Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study." BMJ.com 325.7374 (2002): 1212-3.
description	19.	Cahoy, J. "A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function." The journal of neuroscience 28.1 (2008): 264-278.
description	20.	Sullivan, Patrick F. "A mega-analysis of genome-wide association studies for major depressive disorder." Molecular Psychiatry 18.4 (2012): 497-511.